Evidence map›Paper›PMID 34523134›Full record

ReviewImmunological reviews2021

RNA-binding proteins and RNA methylation in myeloid cells.

Marian Bataclan, Cristina Leoni, Silvia Monticelli

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Senescence-induced p21Cell discovery · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. RNA regulation in immunity.Immunological reviews · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marian BataclanInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Cristina LeoniInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Silvia MonticelliInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.ORCID 0000-0002-5909-8802
Università della Svizzera italiana · CH

Funding

Swiss National Science Foundation 189352
6 · The paper itself

Abstract

RNA-binding proteins (RBPs) regulate all aspects of the life of mRNA transcripts. They are critically important in regulating immune responses, most notably by restraining excessive inflammation that can potentially lead to tissue damage. RBPs are also crucial for pathogen sensing, for instance for the recognition of viral nucleic acids. Concordant with these central regulatory roles, the dysregulated activity of many RBPs can give rise to disease. The expression and function of RBPs are therefore highly controlled by an elaborate network of transcriptional, post-transcriptional and post-translational mechanisms, including the ability of different RBPs to cross-regulate each other's expression. With an emphasis on macrophages and mast cells, we review current knowledge on the role of selected RBPs that have been shown to directly impact the expression of inflammatory transcripts. By focusing specifically on proteins of the Regnase and ZFP36 family, as well as on factors involved in N

Indexed as

ImmunityRNA-Binding ProteinsMethylationMyeloid CellsRNARNARNA-Binding Proteinsm6Amast cellsMyeloid cellsRNA-binding proteinsRNA methylationRNA sensing

Identifiers

PMID34523134
PMCPMC7615035
OpenAlexW3200397040

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.